share_log

10-Q: Q2 2024 Earnings Report

10-Q: Q2 2024 Earnings Report

10-Q:2024財年二季報
美股SEC公告 ·  2024/08/14 16:51

Moomoo AI 已提取核心訊息

Safety Shot Inc. reported Q2 2024 revenue of $710,240, up significantly from $23,305 in Q2 2023, driven by the launch of its Safety Shot Dietary Supplement in December 2023. Gross profit was $205,712 compared to a loss of $4,270 in the prior year period. Cost of sales increased to $504,528 reflecting startup costs associated with the product launch.Operating expenses surged to $8.6 million from $1.7 million year-over-year, primarily due to increased marketing expenses of $2.6 million, legal and professional fees of $1.9 million, and stock-based compensation of $3.0 million. The company employed a comprehensive marketing approach including digital and retail activations, social media, and broadcast events. Research and development costs were $119,911.The company ended the quarter with $3.2 million in cash. Management noted ongoing litigation matters including lawsuits from warrant holders seeking damages. While expressing confidence in vigorously defending these claims, the company acknowledged the need to potentially raise additional capital to execute its business plan, though warrant exercises and marketable securities holdings provide some financial flexibility.
Safety Shot Inc. reported Q2 2024 revenue of $710,240, up significantly from $23,305 in Q2 2023, driven by the launch of its Safety Shot Dietary Supplement in December 2023. Gross profit was $205,712 compared to a loss of $4,270 in the prior year period. Cost of sales increased to $504,528 reflecting startup costs associated with the product launch.Operating expenses surged to $8.6 million from $1.7 million year-over-year, primarily due to increased marketing expenses of $2.6 million, legal and professional fees of $1.9 million, and stock-based compensation of $3.0 million. The company employed a comprehensive marketing approach including digital and retail activations, social media, and broadcast events. Research and development costs were $119,911.The company ended the quarter with $3.2 million in cash. Management noted ongoing litigation matters including lawsuits from warrant holders seeking damages. While expressing confidence in vigorously defending these claims, the company acknowledged the need to potentially raise additional capital to execute its business plan, though warrant exercises and marketable securities holdings provide some financial flexibility.
Safety Shot Inc.報告了2024年第二季度營業收入爲710,240美元,較2023年第二季度的23,305美元大幅增長,這是由於其於2023年12月推出的Safety Shot膳食補充劑所驅動。毛利潤爲205,712美元,而去年同期則虧損4,270美元。銷售成本增加到了504,528美元,反映出與產品推出相關的啓動成本。營業費用從去年的170萬美元大幅攀升至860萬美元,主要是由於營銷費用增加了260萬美元,法律及專業費用爲190萬美元,以及基於股票的補償爲300萬美元。公司採取了綜合營銷方式,包括數字和零售激活、社交媒體及廣播活動。研究與開發費用爲119,911美元。公司在季度末現金餘額爲320萬美元。管理層提到正在進行的訴訟事項,包括尋求賠償的權證持有人的訴訟。儘管表示對積極應對這些索賠的信懇智能,但公司承認需要可能籌集額外資本來執行其業務計劃,儘管權證行使和可交易證券持有提供了一定的財務靈活性。
Safety Shot Inc.報告了2024年第二季度營業收入爲710,240美元,較2023年第二季度的23,305美元大幅增長,這是由於其於2023年12月推出的Safety Shot膳食補充劑所驅動。毛利潤爲205,712美元,而去年同期則虧損4,270美元。銷售成本增加到了504,528美元,反映出與產品推出相關的啓動成本。營業費用從去年的170萬美元大幅攀升至860萬美元,主要是由於營銷費用增加了260萬美元,法律及專業費用爲190萬美元,以及基於股票的補償爲300萬美元。公司採取了綜合營銷方式,包括數字和零售激活、社交媒體及廣播活動。研究與開發費用爲119,911美元。公司在季度末現金餘額爲320萬美元。管理層提到正在進行的訴訟事項,包括尋求賠償的權證持有人的訴訟。儘管表示對積極應對這些索賠的信懇智能,但公司承認需要可能籌集額外資本來執行其業務計劃,儘管權證行使和可交易證券持有提供了一定的財務靈活性。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息